ArticlePDF Available

Neonatal Vaccination with Bacillus Calmette-Guérin and Hepatitis B Vaccines Modulates Hippocampal Synaptic Plasticity in Rats

  • Mayo Clinic

Abstract and Figures

Immune activation can exert multiple effects on synaptic transmission. Our study demonstrates the influence of neonatal vaccination on hippocampal synaptic plasticity in rats under normal physiological conditions. The results revealed that neonatal BCG vaccination enhanced synaptic plasticity. In contrast, HBV hampered it. Furthermore, we found that the cytokine balance shifted in favour of the T helper type 1/T helper type 2 immune response in BCG/HBV-vaccinated rats in the periphery. The peripheral IFN-γ:IL-4 ratio was positively correlated with BDNF and IGF-1 in the hippocampus. BCG raised IFN-γ, IL-4, BDNF and IGF-1 and reduced IL-1β, IL-6, and TNF-α in the hippocampus, whereas, HBV triggered the opposite effects.
Content may be subject to copyright.
Neonatal vaccination with bacillus CalmetteGuérin and hepatitis B
vaccines modulates hippocampal synaptic plasticity in rats
Qingqing Li, Fangfang Qi, Junhua Yang, Luwen Zhang, Huaiyu Gu, Juntao Zou, Qunfang Yuan, Zhibin Yao
Department of Anatomy and Neurobiology, Zhongshan School of Medicine, Sun Yat-Sen University, Guangzhou 510080, China
abstractarticle info
Article history:
Received 20 March 2015
Received in revised form 8 August 2015
Accepted 19 August 2015
Th1/Th2 bias
Immune activation can exert multiple effects on synaptic transmission. Our study demonstrates the inuence of
neonatal vaccination on hippocampal synaptic plasticity in rats under normal physiological conditions. The
results revealed that neonatal BCG vaccination enhanced synaptic plasticity. In contrast, HBV hampered it.
Furthermore, we found that the cytokine balance shiftedin favour of the T helper type 1/T helper type 2 immune
response in BCG/HBV-vaccinated rats in the periphery. The peripheral IFN-γ:IL-4 ratio was positively correlated
with BDNF and IGF-1 in the hippocampus. BCG raised IFN-γ, IL-4, BDNF and IGF-1 and reduced IL-1β, IL-6, and
TNF-αin the hippocampus, whereas, HBV triggered the opposite effects.
© 2015 Elsevier B.V. All rights reserved.
1. Introduction
The immune system plays a pivotal role in modulating nerve injury,
regeneration, and learning and memory, which has been rmly
established over the past two decades (Kohman & Rhodes, 2013;
Perry, 2004; Yirmiya & Goshen, 2011). Immune activation early in
life can signicantly affect the development of neural processes
(Bitanihirwe et al., 2010; Chen et al., 2013; Chugh et al., 2013; Ito
et al., 2010). Global coverage with bovis bacillus CalmetteGuérin
(BCG) and hepatitis B virus (HBV) vaccinations has reached more than
80% for neonates. It has been reported that neonatal vaccination with
BCG inhibited allergic airway inammation in mice and may protect
against tuberculous meningitis (Freyne & Curtis, 2014; Shen et al.,
2008). In addition to BCG, the association between neonatal vaccination
with HBV and autism has also been researched (Gallagher & Goodman,
2010). However, the related reports regarding the role of neonatal vac-
cination have almost all been derived from studies conducted under
pathological conditions. The safety and side effects of neonatal vaccina-
tion are controversial and need to be evaluated in association with
physiological status (Demirjian & Levy, 2009; Hodgins & Shewen, 2012).
According to these reports, the correlation between neonatal vacci-
nation and neural developmental processes warrants investigation.
Although the related reports demonstrate that early-life immune acti-
vation affects brain development and is related to neurodegenerative
diseases, there has been no study reporting whether neonatal vaccina-
tion could inuence brain development in a physiological manner.
Synaptic plasticity is the primary and sensitive model for investigating
brain development. Therefore, the purpose of this study was to investi-
gate the changes in hippocampal synaptic plasticity induced by neona-
tal vaccination.
Previous studies have demonstrated that BCG/HBV vaccination can
induce Th1/Th2 serum cytokine bias (Libraty et al., 2014; Ota et al.,
2002, 2004). The Th1/Th2 cytokine balance could modulate the expres-
sion of neurotrophins in the central nervous system (CNS) (Besser &
Wank, 1999). Based on previous reports, we suggested the hypothesis
that early-life vaccination may alter this normal developmental trajec-
tory of synapses via regulation of the expression of cytokines and
neurotrophins. Hippocampal synaptic plasticity was measured because
it is particularly sensitive to neuroinammation (Min et al., 2009). In
this study, neonatal vaccinationwith BCG/HBV modulated hippocampal
synaptic plasticity, including long-term potentiation (LTP), spine densi-
ty and morphology, and the protein expression of synapses. Interesting-
ly, two opposite alterations of synaptic plasticity were observed to be
induced by BCG or HBV vaccination.
2. Materials and methods
2.1. Subjects
Adult male and female Sprague Dawley (SD) rats (70 days) were
purchased from the Sun Yat-Sen University laboratory animal centre
Journal of Neuroimmunology 288 (2015) 112
Abbreviations: LTP, long-term potentiation; DG, dentate gyrus; BCG, bacillus
CalmetteGuérin; HBV, hepatitis B vaccination; CNS, central nervous system; BDNF,
brain derived neurotrophic factor; IGF-1, insulin-like growth factor 1; EPSP, excitatory
postsynaptic potential.
Corresponding author at: Department of Anatomy and Neurobiology, Sun Yat-Sen
University, #74, Zhongshan No. 2 Road, Guangzhou 510080, China.
E-mail address: (Z. Yao).
0165-5728/© 2015 Elsevier B.V. All rights reserved.
Contents lists available at ScienceDirect
Journal of Neuroimmunology
journal homepage:
(Guangzhou, China) and were raised in same-sex pairs in a specic
pathogen-free facility. The colony was maintained under controlled
temperature (22 ± 2 °C) and articial light under a 12-h cycle, with
water and food available ad libitum. After acclimation to breeding
conditions, males and females were paired into breeders. All experi-
mental protocols were approved by the Institutional Research Ethics
Committee at Sun Yat-Sen University.
2.2. Experimental design
The present study included four sets of newborns. The results of
hippocampal LTP in this study were based on set one; settwo conrmed
morphology ndings; synaptic protein levels were investigated in set
three; and set four was used for cytokine expression analysis. Each set
was included in three experiments,and every experiment was conduct-
ed at the age of 2,4, and 8 weeks. These experimental time points were
chosen because they are distributed across the important age span
when rats grow from juvenile into adults.
Newborn pups were randomly assigned to three experimental
groups and three matched control groups. They were administered
BCG, HBV, or a combination of BCG and HBV and were named the BCG
group, HBV group, and BH group, respectively. The control groups re-
ceived injections of sterile phosphate-buffered saline (PBS) following
the same protocol as that used in the matched experimental group.
Every experiment included six groups (three experimental groups and
three matched control groups) and the four sets of newborns were
conducted at the age of 2, 4, and 8 w, respectively.
2.3. Vaccination
Female rats were visually checked for conrmation of pregnancy,
and male rats were removed from cages before the birth of pups
[postnatal day 0 (P0)]. Female pups were culled to 12 pups per litter
on P0, retaining two females and as many males as possible (Bilbo
et al., 2005). All subjects were males to avoid effects of hormonal varia-
tion in females (Cui et al., 2009).
The BCG and HBV vaccination procedures imitated those used for
human infant vaccinations (Marchant et al., 1999). BCG was adminis-
tered in a single dose at P0,and HBV was administered in a 3-dose series
at P0, P7, and P21. Freeze-dried living Bacillus CalmetteGuérin
(D2-BP302 strain, Biological Institute of Shanghai, Shanghai, China)
was suspended in sterile PBS. Newborn pups were injected intradermal-
ly in the back with 50 μl/rat of BCG suspension containing 10
forming units (CFU) or 50 μl of sterile PBS according to a previously de-
scribed procedure (Kiros et al., 2010). The dose was originally chosen
because it successfully induced an immune response and cytokine pro-
duction in the periphery. In the HBV group and matched CON group,
newborn pups were intraperitoneally injected with a total volume of
100 μl/rat of HBsAg-aluminium-vaccine (20 μg/ml, yeast-derived,
Kangtai Biological Pharmaceutical Company, China) containing ap-
proximately 2 μg HBsAg and an equal amount of PBS. The doses of
HBV (2 μg/rat) and BCG (10
CFU/rat) were chosen based on our pilot
experiments because they were effective without causing obvious
body weight changes (Table S1 and Table S2). Newborn pups in the
BH group were vaccinated with both the BCG and HBV procedures
mentioned above. The newborn pups in the CON groups matched to
the BH group received PBS injections with the same methods as those
used in the BH group. All male pups that underwent synaptic analyses
were weaned on P21 and caged separately in sibling pairs; the remain-
ing female pups were culled.
2.4. Electrophysiology
Newborn pups (2, 4, 8 w) were anaesthetised with urethane (20%
solution, 1.2 g/kg, i.p.) and positioned in a stereotaxic apparatus
(Stoelting Instruments, USA). Body temperature was maintained at
37.0 °C via an electric heating pad. A bipolar concentric tungsten
electrode (Concentric Bipolar Microelectrode, WPI, USA) was used to
stimulate the medial perforant path (coordinates: from bregma, AP,
8.0 mm; ML, 4.4 mm; DV, 22.5 mm below the dura) in the left hemi-
sphere. The stimulating electrode was connected to the output of an
isolator (ISO-ex, AMPI, Israel) connected with a stimulator (Axon
Digidata 1440 A, MDC, USA). A stainless steel, monopolar recording
electrode was inserted into the dentate gyrus (DG) granular cell
(coordinates: from bregma, AP, 3.5 mm; ML, 2.15 mm; DV, 2.53mm
below the dura (Süer et al., 2009)). The depths of the recording elec-
trode was optimised to maximise the excitatory postsynaptic potential
(EPSP), and a superimposed negative population spike (PS) was evoked
with a 0.1 mm step. Then the depth of stimulating electrodes were
adjusted to maximise the PS amplitude in response to the perforant
path stimulation. Two screws in the occipital bone were used as the ref-
erence and ground.
Evoked eld potentials were scored by a population spike (PS). The
test stimulation intensity that produced 50% of the maximum ampli-
tude of the PS was chosen, and the measured test pulse for different an-
imals was between 200 and 400 μA. The test stimuli were performed
every 30 s. Recordings were allowed to stabilise for 20 min, and the
high-frequency stimulation protocol (HFS, 20 trains of 15 pulses at
200 Hz with an inter-train interval of 5 s) was applied to induce LTP.
Following the delivery of the tetanic stimuli, application of the test
stimuli was continued for up to 60 min at 0.033 Hz. The percentage of
the ratio of EPSP slope to the basal value represented the level of
synaptic strength. A slope of EPSP change exceeding 20% was dened
as a successful induction of LTP (Bliss & Collingridge, 1993). The magni-
tude of LTP was between 58 and 60 min in the last bin of the recording
session and was expressed as the percentage change from the PS base-
line. Values from the nal 2-min bin were compared between the
immunised group and the corresponding control group using Student's
2.5. DiOlistic labelling
Dendritic spine density and morphology in DG neurons were
assessed by quantifying spines in neurons labelled with the uorescent
dye (1-1-Dioctadecyl-3,3,3,3-tetramethylindocarbocyanine perchlo-
rate) DiI (CM-DiI, Sigma-Aldrich, USA) in 2-, 4-, and 8-w-old pups
(Erion et al., 2014). Pups were transcardially perfused with 4% parafor-
maldehyde and postxed in the same xative for 12 days at 4 °C.
Coronal brain slices (200 μm free-oating) were cut on a vibratome
(Leica VT 1000S, Bannockburn, IL). Slices were rinsed and stored in
0.1 M phosphate buffer (PB) for DiI delivery. The gene gun bullets
were prepared according to a previously described method (Staffend
&Meisel,2011). Briey, 8 mg of gold particles (1.0 μm in diameter)
was mixedwith 2 mg of DiI (CM-DiI, Sigma-Aldrich, USA) and dissolved
in 300 μl of methylene chloride. After drying, the coated particles were
collected in 2 ml of water, vortexed on a sonicator for 5 min, and imme-
diately transferred to gene gun tubing with a 1-mm diameter (Bio-Rad).
The tube was held still for 1 h before slowly withdrawing the remaining
liquid. Then, we dried the tubing under a constant nitrogen ow for
30 min. The tube was cut into small sections (2 cm in length) and stored
in a desiccated container at 4 °C for up to 1 month.For particle delivery,
slices were transferred to a Petri dish, and most of the PB was then re-
moved. The DiI-coated particles were delivered using the Helios Gene
Gun system (Bio-Rad) at a pressure of 150180 psi. To prevent clusters
of large particles from landing on the tissue, causing non-specic label-
ling and preventing single-cell resolution, a membrane lter was
inserted between the gene gun and the brain sections. After delivery,
slices were incubated overnight in 0.1 M PB at 4 °C to a llow the diffusion
of the dye along the neuronal processes. Finally, the sections were
rinsed 3 times with PB before being mounted on slides and coverslipped
with 65% glycerine in 0.1 M PB.
2Q. Li et al. / Journal of Neuroimmunology 288 (2015) 112
2.6. Photography and confocal imaging
Image acquisition and analysis were performed in a systematic
manner by individuals who were blinded to the treatment. On the
same day, brain sections were imaged on a confocal microscope (LSM
710, Carl Zeiss, Germany) to acquire a stack of images (z-spacing,
1μm) of the apical dendrites from isolated DG granule neurons using
a 63x oil objective (N.A., 1.4) with a DPS of 568nm. Three to ve second-
ary dendrites per neuron were imaged (1024 × 1024 pixels, xy
scaling = 0.0952 μm/pixel), and at least three neurons per rat were col-
lected. All segments were imaged from secondary branches in theapical
dendritic tree at a similar distance from the cell body across genotypes.
Dendritic spine morphology was analysed using the Imaris software
package (Version 7.0, Bitplane Inc., St Paul, MN). Spine density was
determined by manually identifying spines. Spine area and length
were automatically measured in the 3D reconstructive stacks, which
can classify spines into stubby, mushroom, long thin, and lopodia on
the basis of suitable morphological categories.
2.7. Western blot
Hippocampal tissue was harvested from the vaccinated and control
pups at 2, 4, and 8 weeks (n = 4) and homogenised in ice-cold RIPA
lysis buffer containing (in mM) 50.0 TrisHCl, 150 NaCl, 5.0 CaCl
0.02% NaN
, and 1% Triton X-100 in the presence of a protease inhibitor
mixture (1 mM PMSF, protease inhibitor cocktail; Sigma-Aldrich). The
lysates were then centrifuged at 12,000 g for 20 min at 4 °C after incu-
bation in ice for 30 min. The protein concentration was determined
using a BCA Protein Assay Kit (Beyotime). The samples (20 μlper
lane) were separated by 8% sodium dodecyl sulphate-polyacrylamide
gel electrophoresis (SDS-PAGE) and electro-transferred onto a
polyvinylidenediuoride (PVDF) membrane (Bio-Rad Lab, Hercules,
CA, USA) at 60 V for 30 min and then 90 V for 1 h. Membranes were
blocked with 5% non-fat milk in TBS for 2 h at room temperature. The
following primary antibodies were used at the given concentrations:
synaptophysin (1:500; Sigma-Aldrich), PSD-95 (1:2000; Sigma-
Aldrich), NMDAR2A (1:1000; Millipore), NMDAR2B (1:1000;
Millipore), NMDAR1 (1:1000; Cell Signalling Technology), and
β-tubulin (1:1000; Beyotime). Membranes were then rinsed for
10 min three times in PBST (100 nM phosphate buffer, pH 7.5, contain-
ing 150 nM NaCl and 0.1% Tween-20) and incubated with a horseradish
peroxidase (HRP)-conjugated secondary antibody (1:5000; Sigma-
Aldrich) at room temperature for 2 h. Immunoblots were developed
on lms using the enhanced chemiluminescence technique (Pierce
Chemical Co., Rockford, IL, USA). The intensities of protein bands were
quantied and analysed using the NIH Image J software. All assays
were performed at least three times.
2.8. Enzyme-linked immunosorbent assay (ELISA)
The levels of IFN-γ, IL-4, TNF-α, IL-6, and IL-1βin serum and in
the hippocampus were assessed in duplicate via an ELISA kit
(Neobioscience Technology Co., Ltd) as described previously (Xia
et al., 2014a). The hippocampal samples were homogenised as de-
scribed above by Western blotting. The levels of neurotrophic factors
in the hippocampus were measured by an ELISA kit (Cusabio Life Sci-
ence Co., Ltd) according to an optimised manufacturer's protocol at 2,
4, and 8 weeks. Samples were homogenised on ice in buffer (pH 7.6)
containing (in mM) 50.0 TrisHCl, 150 NaCl, 5.0 CaCl
, 0.02% NaN
and 1% Triton X-100 and then centrifuged at 17,000 ×gfor 30 min at
4 °C. The total hippocampal homogenate concentration was adjusted
to 4.5 mg/ml by using an Enhanced BCA Protein Assay Kit (Beyotime)
according to a previous report (Selenica et al., 2013). The prepared
plates were analysed by the microplate reader (BIO-TEk ELx800, USA)
at 450 nm.
2.9. Statistical analysis
Data are presented as the means ± SEM. Differences between
groups were evaluated by two-way (vaccination × time) ANOVA
followed by Bonferroni post-hoc test using SPSS 17.0. The analysis of
the correlation between the IFN-γto IL-4 ratio and BDNF/IGF-1 wasper-
formed using Pearson correlation analysis. Statistical signicance was
set to pb0.05, and analyses were performed using Graph Pad Prism
5.0 (GraphPad Software).
3. Results
3.1. Neonatal vaccination and antibody levels
Each group of rats was administered BCG (BCG group), HBV (HBV
group), or a combination of BCG and HBV (BH group) on P0. The
serum anti-HBsAg antibody and anti-BCG titres of all control rats were
kept at a baseline level. There was a signicant increase in antibody
titres in the HBV/BCG vaccinated rats compared with their control
groups at all three time points (2, 4, and 8 weeks; Table S1 and
Table S2). The increase was also observed in the BH groups. No signi-
cant differences were observed in physical conditions, such as weight,
between the vaccinated rats and the controls (Table S1 and Table S2).
3.2. Neonatal vaccination affects hippocampal LTP in vivo
To investigate the effects of neonatal vaccination on synaptic plastic-
ity, we examined LTP in the DG area in vivo at 2, 4, and 8 weeks postna-
tal. Two-way ANOVA revealed signicant main effects of BCG (F
12.20, P = 0.002). Subsequent analysis revealed that BCG vaccination
facilitated the induction of hippocampal LTP at 2 weeks (166.20 ±
9.11%, p= 0.01, Fig. 1A and E) and 4 weeks (173.22 ± 7.27%,
p= 0.016, Fig. 1B and E) compared with the controls. There was no sig-
nicant main effects of HBV, time or signicant interactions of
HBV × time. However, Subsequent analysis revealed that HBV vaccina-
tion inhibited hippocampal LTP at 8 weeks (126.12 ± 6.21%, p=0.017,
Fig. 1C and F). Interestingly, there was no signicant difference in LTP
between the BH group and the control group (Fig. 1D and G), which sug-
gested that these two vaccines may counteract each other to a certain
extent. Notwithstanding, these data indicated that neonatal BCG and
HBV vaccination indeed inuenced the synaptic activity in the hippo-
campus; moreover, the initial effect of BCG vaccination occurred at 2
weeks, whereas that of HBV was delayed to 8 weeks.
3.3. Neonatal vaccination inuences dendritic spine density on hippocam-
pal DG granule cells
Dendrites receive and process synaptic inputs from other neurons
(Kampa et al., 2007). To elucidate whether the cellular mechanisms of
LTP include the formation of new synapses or the remodelling of
existing synapses, numerous studies have examined the number and
structure of synapses following hippocampal LTP (Geinisman, 2000;
Urbanska et al., 2012). To determine the morphological basis for the
change in hippocampal LTP following neonatal vaccination, we investi-
gated spine density, length, and area in hippocampal granule neurons at
2, 4, and 8 weeks. DiOlistic labelling was used to label spines. Although
both neurons and neuroglia werelabelled with DiI, they could be clearly
distinguished on the basis of their morphological features (Cui et al.,
2010). Granule cell bodies, apical dendrites, several lateral and basilar
dendrites, and even dendritic spines could be recognised. There were
signicant main effects of BCG (F
1, 48
= 4.03, P = 0.049), time
2, 48
= 35.13, P = 0.000) and interaction of BCG × time (F
2, 48
3.49, P = 0.039) on the density of spines. Moreover, signicant main
effects of BCG (F
1, 48
= 10.89, P = 0.002) and time (F
2, 48
P = 0.000) on the area of spines were observed. Subsequent analysis re-
vealed that BCG vaccination increased the spine density at 4 w (11.39 ±
3Q. Li et al. / Journal of Neuroimmunology 288 (2015) 112
1.33 10 μm
,n= 9 neurons, p= 0.001, Fig. 2B) and the spine area at 2
and 4 weeks (5.49 ± 0.26 μm
,p= 0.021; 13.72 ± 0.17, p= 0.032,
n= 9 neurons, Fig. 2C) compared with their controls. In contrast, HBV
vaccination reduced the spine density (HBV: F
1, 48
= 4.86, P = 0.033,
time: F
2, 48
= 9.85, P = 0.000) and area (time: F
2, 48
P = 0.000, HBV × time: F
2, 48
= 3.69, P = 0.033) at 8 weeks (HBV vs
CON: density: 5.00 ± 0.52 10 μm
,n= 10 neurons, p=0.01,
Fig. 2B. Area: 2.45 ± 0.15 μm
,n= 10 neurons, p= 0.015, Fig. 2C).
Consistent with previous ndings, the BH group showed no signicant
difference in spine density or area (Fig. 2B and C). No signicant alterna-
tions were observed with respect to the spine length between any two
groups (Fig. 2D). Altogether, there is a close correlation between hippo-
campal LTP and dendritic spine number and structure, suggesting that
the functional and structural plasticity of synapses occurred simulta-
neously following neonatal vaccination. A total of three dendritic
segments per neuron, three neurons per pup, and three to ve pups
were averaged to yield the mean spine density and area for each rat.
3.4. Neonatal vaccination changes the dendritic spine morphology on
hippocampal DG granule cells
The number of spines and their morphology have been demonstrat-
ed to be important for information processing and are associated with
hippocampal LTP (Geinisman, 2000; Urbanska et al., 2012). The plastic
changes in spine morphology reecting the dynamic state of the correl-
ative synapse are responsible to some extent for neuronal circuitry
remodelling (Alvarez & Sabatini, 2007). Therefore, we assessed the
density of the dendritic spines according to their specic morphology
(lopodia, long thin, stubby, and mushroom) by DiOlistic labelling.
Our ndings revealed that BCG caused a selective increase in mushroom
spines (BCG: F
1, 48
= 5.21, P = 0.029, time: F
2, 48
= 32.19, P = 0.000,
BCG × time: F
2, 48
= 6.11, P = 0.022) on hippocampal DG granule
cells at 4 weeks (BCG vs CON: P = 0.017, Fig. 3B), whereas there was
a signicant reduction in the number of stubby spines (HBV: F
1, 48
7.98, P = 0.009, time: F
2, 48
= 22.59, P = 0.000, BCG × time: F
2, 48
17.11, P = 0.002) in the HBV group at 8 weeks (HBV vs CON:
p=0.037,Fig. 3C). In line withthe previous results,no signicant differ-
ences were observed between the BH and CON groups (Fig. 3D). There-
fore, it was inferred that the selective increase or reduction in
mushroom and stubby spines, which have bigger heads, may contribute
to the alterations in overall spine density and area.
3.5. Neonatal vaccination affects the expression levels of synaptic proteins
in the hippocampus
Synaptophysin is the major integral membrane protein of synaptic
vesicles (Thiel, 1993). The main functions of synaptophysin are docking,
fusion, and endocytosis, otherwise known as membrane trafcking
(Evans & Cousin, 2005). PSD-95, the major scaffolding protein contrib-
uting to the excitatory postsynaptic density (PSD) and a potent regula-
tor of synaptic strength, has been considered a key synaptic protein that
promotes synapse stability (Chen et al., 2011; Taft & Turrigiano, 2014). It
is known that the induction of hippocampal LTP requires synaptic acti-
vation of postsynaptic NMDA receptors (Citri & Malenka, 2008).
Fig. 1. Effects of neonatal vaccination with BCG, HBV, and BH on hippocampal LTP in vivo. (A) Representative traces (left) of PS before (basal) and after (60 min) HFS. BCG vaccination
facilitated the induction of hippocampal LTPat 2 weeks (A) and 4 weeks (B) compared with controls. In contrast, HBV vaccination inhibited the induction of LTP at 8 weeks (C) . BH vac-
cination caused no profound alterations at 2, 4, or 8 weeks compared with their controls (D). (E, F, and G) Summary histograms representing the effects of BCG (E), HBV (F), and
BH (G) vaccination on LTP at 60 min post-HFS. Data are presented as the means ± SEM and were analysed with two-way ANOVA followed by Bonferroni post-hoc test. n=67 for
each group. *pb0.05.
4Q. Li et al. / Journal of Neuroimmunology 288 (2015) 112
Fig. 2. Alterations in the dendritic spinelength, area, and densityof granule cellsin the DG of the rats vaccinated withBCG, HBV, and BH. (A) A DiOlisticassay was used to visualisedendritic
spines in granule cells.Individual granulecell at 2, 4, and 8 weeks, respectively (left), representative sections of lateral dendritesin the CON, BCG, HBV, and BH groups at 2, 4, and 8 weeks.
The magniedimages are on the right. BCG vaccination increased thespine density at 4 weeks (B) and the spine area at 2 and 4 weeks (C) compared with the controls. Conversely, HBV
vaccination reducedthe spine area and densityat 8 weeks (B and C). BH-vaccinatedrats showed no signicant difference in spine density or area (B and C). No profound alterations were
observed inthe spine length between any two groups at any of thethree time points (D).Data are presented as the mean ± SEM and were analysed with two-way ANOVA followed by
Bonferroni post-hoc test. n= 9 neurons (3 dendritic segments per neuron, 3 neurons per pup, and 3 pups). *pb0.05 versusvehicle control. Scale bar, 10 μm (left), 5 μm(right).
Fig. 3. Alterations in the morphology of thedendritic spines in the hippocampusof vaccinated rats. (A)Representative photomicrograph depictsdifferent morphological subtypes of den-
driticspines in relation to the dendritic shaft.BCG vaccinationincreased the densityof mushroom spines at4 weeks (B). HBVvaccination decreased the densityof stubby spines at 8 weeks
(C). Data arepresented as the means± SEM and were analysed with two-wayANOVA followed by Bonferroni post-hoc test. n= 9 neurons(3 dendritic segments per neuron, 3 neurons
per pup, and 3 pups). For all graphs, *pb0.05 versus vehicle control and scale bar = 5 μm.
5Q. Li et al. / Journal of Neuroimmunology 288 (2015) 112
Therefore, we applied a Western blotting technique to assess whether
the synaptic proteins were subject to modulation by neonatal vaccina-
tion. It was demonstrated that BCG vaccination promoted the expres-
sion of hippocampal synaptophysin (BCG: F
1, 30
= 12.29, P = 0.001,
time: F
2, 30
= 13.22, P = 0.000. BCG vs CON: p= 0.002, Fig. 4B),
PSD-95 (BCG: F
1, 30
= 5.90, P = 0.028, time: F
2, 30
P = 0.000) and NMDAR2A (BCG: F
1, 30
= 4.47, P = 0.043, time:
2, 30
= 7.91, P = 0.002. BCG vs CON: p=0.01,Fig. 4F) at 4 weeks.
Fig. 4. NeonatalBCG, HBV, and BH vaccinations affect the expression ofsynaptophysin, PSD-95, NMDAR2A, NMDAR2B, and NMDAR1 in the hippocampus. (A,C, E, G and I) Representative
immunoblots of synaptic proteinsat 3 time points. BCGincreased the synaptophysin(B), PSD-95 (D) and NMDAR2A (F) protein levelsat 4 weeks comparedwith the controls.Conversely,
HBV vaccination reduced the synaptophysin, PSD-95, NMDAR2A, and NMDAR2B levels at 8 weeks (B, D, F and H). BH rats showed no signicant changes in synaptic proteins. Data are
presented as the mean ± SEM and were normalised to the matched control. Two-way ANOVA followed by Bonferroni post-hoc test. n= 4 per group. *pb0.05 and **pb0.01 versus
the control group.
6Q. Li et al. / Journal of Neuroimmunology 288 (2015) 112
Conversely, HBV vaccination decreased their expressions at 8 weeks
(synaptophysin: HBV: F
1, 30
= 5.15, P = 0.031, time: F
2, 30
= 16.74,
P = 0.000. HBV vs CON: p= 0.012, Fig. 4F; PSD-95: NMDAR2A: HBV:
1, 30
2, 30
= 12.64, P = 0.002. HBV vs
CON: p= 0.000; NMDAR2B: HBV: F
1, 30
= 5.61, P = 0.025, time:
2, 30
= 14.02, P = 0.001. HBV vs CON: p= 0.042. Fig. 4B, D, F, and
H). No signicant changes wereobserved in these proteins in the hippo-
campus between the BH and control groups. The results indicated that
the alterations in the synaptic proteins may be associated with spine
density and morphology because PSD-95, which is one of the most
abundant PSD proteins, is involved in synapse maturation (El-Husseini
et al., 2000; Prange & Murphy, 2001).
3.6. Neonatal vaccination altersthe levels of cytokines and neurotrophins in
serum and the hippocampus
Cytokines and neurotrophins play a critical role in the process of
brain development under physiological/pathological conditions such
as synaptic plasticity (Erion et al., 2014). Therefore, we considered the
potential implications of the immune-related diffusible mediator in
modulating synaptic plasticity and neural network functioning.
Research in this eld has focused on several pro-inammatory cyto-
kines, such as IL-1β, IL-6, and TNF-α, as having a detrimental effect on
neuronal function and synaptic plasticity (Spedding & Gressens,
2008). However, IFN-γ, IL-4, BDNF, and IGF-1 are regarded as neuro-
trophic factors (Yirmiya & Goshen, 2011). Therefore, we investigated
potential changes in the mediators related to immune activation and
synaptic plasticity. The levels of cytokines and neurotrophins are
shown in Table S3 (serum) and Table S4 (hippocampus). Our data re-
vealed that the BCG group displayed a neurotrophic expression prole
of increased IFN-γ, IL-4, BDNF, and IGF-1 and decreased TNF-α, IL-1β,
and IL-6 at 2 and 4 w, whereas the HBV group exhibited a neurotoxic ex-
pression prole of increased TNF-αand IL-6 and decreased IFN-γ,BDNF,
and IGF-1 at 8 w (see Fig. 5). Interestingly, the BH group exhibited no
signicant changes in serum molecules, but it exhibited slight alter-
ations in the hippocampus compared with the controls. According to
these data, the expression of cytokines and neurotrophins was altered
in both serum and the hippocampus after neonatal vaccination. More-
over, the altered trend was almost the same in serum and the hippo-
campus, which suggested that there wasan internal link between them.
3.7. Neonatal vaccination switches the bias of Th1 or Th2 in serum
Recent animal studies on ageing have indicated that hippocampal
neurogenesis is associated with a decrease in the Th1/Th2 bias
(Baruch et al., 2013). Therefore, to evaluate whether neonatal vaccina-
tion regulates the Th1/Th2 bias, we assessed the ratio of classical
serum cytokine IFN-γ(Th1) to IL-4 (Th2). Consistent with the previous
reports (Libraty et al., 2014; Marchant et al., 1999; Ota et al., 2002,
2004), our ndings conrmed that BCG induced a Th1-like response at
2 weeks (BCG: F
1, 30
= 8.28, P = 0.007, time: F
2, 30
= 3.8, P = 0.034,
BCG vs CON: p= 0.043, Fig. 6A). In contrast, HBV induced a Th2-like re-
sponse at 8 weeks (HBV: F
1, 30
= 7.48, P = 0.01, time: F
2, 30
= 29.65,
P = 0.000, HBV vs CON:p=0.012,Fig. 6A). Moreover, no signicant dif-
ference was observed in the BH group. The association between the
Th1/Th2 bias and the central cytokine and neurotrophin milieu and,
thus, the impact on synaptic plasticity were further demonstrated by
the positive correlation between the IFN-γ:IL-4 ratio and BDNF (2 w:
= 0.572, p= 0.000; 4 weeks: r
= 0.507, p= 0.002; 8 weeks:
= 0.386, p=0.02;n= 36; Pearson correlation analysis; Fig. 6B)
and IGF-1 (2 weeks: r
= 0.518, p= 0.001; 4 weeks: r
= 0.472,
p= 0.004; 8 weeks: r
= 0.131, p=0.446;n= 36; Pearson correlation
analysis; Fig. 6B) levels.Interestingly, the results showed decreased cor-
relation coefcients between the IFN-γ:IL-4 ratio and BDNF and IGF-1
levels as time progressed.
4. Discussion
Our ndings support the hypothesis that neonatal vaccination with
BCG or HBV modulates hippocampal synaptic plasticity probably via
the neuro-benecial or neuro-detrimental expression proles of hippo-
campal cytokines and neurotrophins. BCG vaccination facilitated the
induction of hippocampal LTP, increased the spine density and area,
elicited a selective increase in mushroom spines in the hippocampal
DG area, and elevated hippocampal synaptophysin, PSD-95, and
NMDAR2A protein levels. Conversely, HBV vaccination showed almost
inverse alterations of all these aspects. In this study, BCG induced a
Th1-like response followed by increased neurotrophins in the brain,
whereas HBV induced a Th2-like response followed by decreased
neurotrophins. In addition, positive correlations between the IFN-γ:IL-
4 ratio and BDNF and IGF-1 were observed. Interestingly, BH showed
no obvious shift to either a Th1 or Th2 response and no signicant inu-
ence on synaptic plasticity.
LTP is the most extensively studied model of the cellular mecha-
nisms of synaptic plasticity (Bliss & Collingridge, 1993; Bliss & Lomo,
1973). In the present study, PP-DG LTP was determined based on the
particular sensitivity of the DG structure to both endogenous and
exogenous signals, such as immune activation and pro-inammatory
cytokines, particularly IL-1βand TNF-a (Beattie et al., 2002; Di Filippo
et al., 2008). The present study demonstrated that neonatal BCG vacci-
nation transiently facilitated the induction of hippocampal LTP in rats.
However, HBV impaired hippocampal LTP. These data conrm our spec-
ulation that altered immune status induced by vaccination modulates
hippocampal synaptic plasticity during early life, which is different
from immune activation models induced by LPS, poly (I:C), and
Escherichia coli (E. coli) under pathological conditions.
Dendritic spines are important and pleomorphic structures in the
collection, integration, and transmission of neural signals. Thus, the al-
terations of spine density and morphology may contribute to hippo-
campal LTP. We found that the changes in spine area and density
were consistent with the results of hippocampal LTP in the DG area. It
should be noted that only two subtypes of dendritic spines, namely,
stubby and mushroom (mature and stable, with bigger heads that
allow the passage of more current (Zhao et al., 2006; Urbanska et al.,
2012)), were altered in granule neurons in the DG area in BCG/
HBV-vaccinated rats (BCG rats/HBV rats), and no difference was
observed in immature dendritic subtypes (thin and lopodia) in either
experimental group. Together with spine density and area, the subse-
quent potential alterations in mature and efcient spine subtypes may
contribute to the performance of hippocampal LTP in BCG and HBV
rats. Recent evidence suggests that activated immune cells secrete cyto-
kines and growth factors, which can modulate synaptic transmission
(Henneberger et al., 2005; Pickering et al., 2005) and alter dendritic
spine morphology (Schratt et al., 2006; von Bohlen und Halbach et al.,
2006). The opposite ndings regarding spine density and morphology
between the BCG and HBV rats may be due to the different cytokine
and neurotrophin networks induced by neonatal vaccination with
In addition to the structural plasticity of dendritic spines, the func-
tional plasticity and molecular mechanisms involved in regulating syn-
aptic transmission also require exploration. Both of these mechanisms
may potentially contribute to the alterations in LTP observed in vacci-
nated rats. The synapse proteins, including synaptophysin, PSD-95,
and NMDA receptors, play an important role in synaptic plasticity
(Kamphuis et al., 1992; Liu et al., 2004; Monyer et al., 1992). Therefore,
the modulation of these proteins by immune activation may inuence
synaptic transmission. Our ndings showed that changes in synaptic
proteins were almost parallel to the changes in LTP, spine density, and
morphology. Based on these results, altered synaptic proteins induced
by vaccination may be another contributory factor to the induction of
hippocampal LTP observed in vaccinated rats. The BCG vaccination-
induced increase in spine density and synaptic proteins may represent
7Q. Li et al. / Journal of Neuroimmunology 288 (2015) 112
an enhanced excitatory synaptic connectivity in the early stage of
synaptogenesis. Accordingly, it has been reported that there was a
correlation between spine density, PSD-95, and the inammatory
environment (Chugh et al., 2013; Jakubs et al., 2006). Although recent
studies have demonstrated that inammatory cytokines participate in
physiological and pathological events depending on PSD-95 protein
level or NMDA receptor activation (Gardoni et al., 2011), how the
vaccination-related cytokine network modulates the expression of
synaptic proteins remains elusive.
The most important question for further study is the underlying
mechanism mediating synaptic transmission and structure and the po-
tential difference between the two vaccines. It has been reported that
early life events altered this normal developmental trajectory of the
brain, specically synaptic plasticity, via their specic impact on cyto-
kine and neurotrophin expressions (Goshen et al., 2007; Yirmiya &
Goshen, 2011). Therefore, the hippocampal homogenate was collected
to determine the prole of these mediators in relation to immune acti-
vation. IL-1β, IL-6, and TNF-a, which have been associated with cogni-
tive decline, inhibited synaptic plasticity and caused hippocampal LTP
impairment in previous studies (Balosso et al., 2008; Viviani et al.,
2003; Viviani et al., 2006). It has also been demonstrated that both
IL-4 and IFN-γcontribute to hippocampal LTP and neurogenesis
(Nolan et al., 2005; Zhu et al., 2011). In line with previous reports, our
results showed that the levels of IL-4 and IFN-γwere signicantly
Fig. 5. Neonatal BCG, HBV,and BH vaccination alters the levels of cytokines and neurotrophins in the hippocampus and serum.The levels of IL-1β, IL-6, TNF-α,IL-4,IFN-γ,BDNF and IGF-1
in serum(A, B and C) and the hippocampus (D,E, F, G, H and I) were normalised andanalysed at 2, 4, and8 weeks. In serum, BCGvaccination up-regulatedIL-4 at 4 weeks (B) andIFN-γat
2 weeks (A)and 4 weeks (B), whereasit down-regulatedIL-1βand TNF-αat2 weeks (A) and 4 weeks(B) and down-regulated IL-6 at4 weeks (B). HBV vaccination up-regulatedthe level
of IL-6 at 8 weeks (C), which decreasedthe level of IFN-γat 2 weeks (A),4 weeks (B), and 8 weeks (C)and decreased the level of IL-4 at 2 weeks (A) and 8 weeks (C). Alterationsin the
hippocampus werealmost consistentwith those in serum(D, E and F). BCG vaccination increased the expressionof BDNF and IGF-1 at 2 weeks(G) and 4 weeks (H),whereas HBV decrease
them at 8 weeks (I). Data are presented as the means ± SEM normalised to the controls and were analysed with two-way ANOVA followed by Bonferroni post-hoc test. n= 6 for each
group. *pb0.05, **pb0.01, and ***pb0.001 versus the control group.
8Q. Li et al. / Journal of Neuroimmunology 288 (2015) 112
increased in the hippocampus of BCG rats, whereas the levels of IL-1β,IL-
6, and TNF-a, known to be detrimental to LTP, were reduced.
Importantly, the concentrations of BDNF and IGF-1, which are thought
to enhance brain functional plasticity (Nolan et al., 2005), were up-
regulated in the BCG rats. In contrast to BCG, those levels declined in
the HBV rats. Interestingly, the BH rats showed no signicant alterations
in these cytokines and neurotrophins in the brain. These data indicated
that the alterations in synaptic plasticity regulated by the cytokine net-
work were accompanied by the alterations in neurotrophins, such as
IL-4, BDNF, and IGF-1, which modulate synaptic efcacy and neurotrans-
mission (Figurov et al., 1996; Levine et al., 1995; Neal-Perry et al., 2014).
Previous studies have demonstrated that manipulations of individu-
al cytokines can modulate learning, memory, and synaptic plasticity.
However, there are many conicting ndings that have prevented a
clear understanding of the precise role of cytokines in synaptic plastici-
ty. Given the complexity of inammatory signalling, we speculated that
it is primarily the cytokine network that contributes to the ne-tuning
of neural transmission rather than an individual cytokine (Xia et al.,
2014a). In our study, the levels of cytokines in the hippocampus
displayed similar trend as those in the serum, which suggests a close co-
incidence between the brain and peripheral blood system. It has been
reported that peripheric cytokines may permeate into the CNS and
affect neuronal transmission directly (Banks, 2005). The interplay be-
tween cytokines and neurotrophins is complex. Neurotrophins can be
secreted by several types of immune cells, including T cells, microglia,
macrophages, and mast cells (Elkabes et al., 1996; Nakajima et al.,
2001). Cytokines in the CNS have crosstalk with resident immune cells
(e.g., microglia) and regulate their phenotypes and therefore alter
their local molecule production, including cytokines and neurotrophins
(Schwartz and Shechter, 2010).
BCG or HBV vaccination induced a shift toward a dominance of the
Th1 or Th2 response, respectively. Given that mediator-related
Fig. 6. Neonatal BCG, HBV, and BH vaccination alters the Th1/Th2 bias. BCG vaccination induced a Th1-like response, while HBV led to a Th2-like response in the periphery. Bars in
(A) represent the fold-change ofthe average concentration of IFN-γwith respect to that of IL-4 in each group in serum. Dataare presented as the means ± SEM normalised to the control
and were analysed with two-way ANOVA followed by Bonferroni post-hoc test. n= 6 for each group (A). Correlation analysis was performed using the serum IFN-γ:IL-4 ratio and the
hippocampal BDNF or IGF-1 level (B). Pearson correlation analysis (BDNF: 2 weeks, r
=0.572,pb0.01; 4 weeks, r
= 0.507, pb0.01; 8 weeks, r
= 0.386, pb0.05; IGF-1: 2 weeks,
=0.518,pb0.01; 4 weeks, r
= 0.472, pb0.01; n=36).
9Q. Li et al. / Journal of Neuroimmunology 288 (2015) 112
immunity in the hippocampus resulted from immune activation in the
periphery, the positive correlation between systemic Th1:Th2 ratios
and hippocampal neurotrophins bridges the vaccination and neurogen-
ic niche and explains the change in synaptic plasticity.
Furthermore, it has been conrmed that the Th1/Th2 cytokine bal-
ance can modulate neurotrophin expression and, thus, affect neuronal
function (Besser & Wank, 1999). Thus, an integrated network is formed
between the extrinsic Th1/Th2 serum cytokines followed by intrinsic
CNS-derived cytokines and the neurotrophin network to build a
benecial/detrimental neurogenic niche. Therefore, we propose a hy-
pothesis that a systemic Th1/Th2 bias modulates central cytokines and
neurotrophins andthereby affects theneurogenic niche, which istightly
correlated with synaptic plasticity. Previous reports support this hy-
pothesis. It was reported that cognitive decit was related to decreased
Th1/Th2 balance in periphery and could be recoveredwhen the balance
was restored (Jakobsson et al., 2014; Palumbo et al., 2012). In addition
to this, inuenza vaccines administered during pregnancy induced a
systemic Th1 bias and increased neurotrophins in both dams and their
offspring (Xia et al., 2014a; Xia et al., 2014b). Inour study, the probable
underlying mechanism of the Th1/Th2 bias modulating synaptic plastic-
ity was demonstrated by the following results: 1) BCG vaccination in-
duced a Th1 serum cytokine response and yielded benecial effects on
synaptic plasticity; conversely, HBV induced a Th2 bias and exerted det-
rimental effects; 2) the correlation analysis showed a positive correla-
tion between systemic Th1:Th2 ratios and hippocampal BDNF and
IGF-1 levels; 3) it has been demonstrated that BDNF and IGF-1 contrib-
ute to the enhancement of synaptic transmission (Figurov et al., 1996;
Levine et al., 1995; Neal-Perry et al., 2014); and 4) BH vaccination
showed no obvious shift in Th1 or Th2, and no signicant effects were
observed on synaptic plasticity. In summary, the possibility arises that
altered synaptic plasticity during early life may be modulated by the
balance of two forces, namely, intrinsic CNS-derived signals and
extrinsic signals that permeate to the CNS. However, the underlying
mechanism is complex and diverse. Other mechanisms may exist and
require further study, such as the neuro-protective or neurotoxic
microglial cells reactivity to TH1/TH2 response. Moreover, the implica-
tion of immune molecules, such as MHC of class I, toll like receptors
and complement system, which have been recently related to neonatal
synaptic plasticity, may contribute to the alteration of synaptic
Interestingly, we found a decline in the correlation coefcients
between the IFN-γ:IL-4 ratio and BDNF and IGF-1 levels as time
progressed, which may explain why the effect on synaptic plasticity
induced by neonatal vaccination disappeared with age. Although we
speculated that the inuence on synaptic plasticity induced by neonatal
vaccination was associated with Th1/Th2 bias accompanied by changes
in BDNF and IGF-1, other immune cells, such as regulatory T lympho-
cytes and local microglia affected by immune activation, also play criti-
cal roles in modulating synaptic plasticity (Lagranderie & Guyonvarc'h,
2014; Yong et al., 2011).
We found that the timing of the effect on synaptic plasticity was
different between the BCG and HBV rats. This may be due to immune
reactions, bacterial/virus antigens, or the humoral/cellular immune
response that contribute to different latencies. It is well known that
the cellular immune response is activated faster than the humoral
immune response under normal physiological conditions, which may
explain why BCG vaccination is more quickly effective in synaptic struc-
tures and transmission than HBV. However, the present analysis re-
mains speculative, and the reason for this speculation is considerably
complicated and requires further exploration.
In summary, we worked specically with a model of neonatal vacci-
nation in rats that modulates hippocampal synaptic plasticity. The pres-
ent ndings provide innovative information regarding the correlation
between neonatal vaccination and synaptic transmission. Moreover,
our data suggested that combinationsof different vaccines can mutually
interact (enhance or counteract). The mechanism of synaptic plasticity
modulation through neonatal BCG/HBV vaccination may be via systemic
Th1/Th2 bias accompanied by a specicprole of cytokines and
neurotrophins in the brain. Our work highlights a critical role of
neonatal vaccination in synaptic plasticity outside of infectious disease
prevention, which suggests the necessity of further studies on the asso-
ciation of vaccination with brain development under normal physiolog-
ical conditions.
The authors thank Prof. Huaiyu Gu and Prof. Juntao Zou for their
technical assistance, as well as Qunfang Yuan for technical guidance.
This work was supported by National Natural Science Foundation of
China (No. 31371130),and the Science and Technology Planning Project
of Guangdong Province, China (No. 2009B080701089). The authors
declare no competing nancial interests.
Appendix A. Supplementary data
Supplementary data to this article can be found online at http://dx.
Alvarez, V.A., Sabatini, B.L., 2007. Anatomical and physiological plasticity of dendritic
spines. Annu Rev Neurosci 30, 7997.
Balosso, S., Maroso, M., Sanchez-Alavez, M., Ravizza, T., Frasca, A., Bartfai, T., Vezzani, A.,
2008. A novel non-transcriptional pathway mediates the proconvulsive effects of
interleukin-1beta. Brain 131, 32563265.
Banks, W.A., 2005. Blood-brain barrier transport of cytokines: a mechanism for neuropa-
thology. Curr Pharm Des. 11, 973984.
Baruch, K., Ron-Harel, N., Gal, H., Deczkowska, A., Shifrut, E., Ndifon, W., Mirlas-Neisberg,
N., Cardon, M., Vaknin, I., Cahalon, L., Berkutzki, T., Mattson, M.P., Gomez-Pinilla, F.,
Friedman, N., Schwartz, M., 2013. CNS-specic immunity at the choroid plexus shifts
toward destructive Th2 inammation in brain aging. Proc Natl Acad Sci U S A 110,
Beattie, E.C., Stellwagen, D., Morishita, W., Bresnahan, J.C., Ha, B.K., Von Zastrow, M.,
Beattie, M.S., Malenka, R.C., 2002. Control of synaptic strength by glial TNFalpha. Sci-
ence 295, 22822285.
Besser, M., Wank, R., 1999. Cutting edge: clonally restricted production of the
neurotrophins brain-derived neurotrophic factor and neurotrophin-3 mR NA by
human immune cells and Th1/Th2-polarized expression of theirreceptors. J Immunol
162, 63036306.
Bilbo, S.D., Biedenkapp, J.C., Der-Avakian, A., Watkins, L.R., Rudy, J.W., Maier, S.F., 2005.
Neonatal infection-induced memory impairment after lipopolysaccharide in adult-
hood is prevented via caspase-1 inhibition. J Neurosci 25, 80008009. http://dx.doi.
Bitanihirwe, B.K., Peleg-Raibstein, D., Mouttet, F., Feldon, J., Meyer, U., 2010. Late prenatal
immune activation in mice leads to behavioral and neurochemical abnormalities rel-
evant to the negative symptoms of schizophrenia. Neuropsychopharmacology 35,
Bliss, T.V., Collingridge, G.L., 1993. A synaptic model of memory:long-term potentiation in
the hippocampus. Nature 361, 3139.
Bliss, T.V., Lomo, T., 1973. Long-lasting potentiation of synaptic transmission in the den-
tate area of the anaesthetized rabbit following stimulation of the perforant path. J
Physiol 232, 331356.
Chen, X., Nelson, C.D., Li, X., Winters, C.A., Azzam, R.,Sousa, A.A., Leapman, R.D., Gainer, H.,
Sheng, M., Reese, T.S., 2011. PSD-95 is required to sustain the molecular organization
of the postsynaptic density. J Neurosci 31, 63296338.
Chen, Y.H., Kuo, T.T., Chu,M.T., Ma, H.I., Chiang, Y.H., Huang, E.Y., 2013. Postnatal systemic
inammation exacerbates impairment of hippocampal synaptic plasticity in an ani-
mal seizure model. Ne uroimmunomodu lation 20, 223232.
Chugh, D., Nilsson, P., Afjei, S.A., Bakochi, A., Ekdahl, C.T., 2013. Brain inammation induces
post-synaptic changes during early synapse formation in adult-born hippocampal neu-
rons. Exp Neurol 250, 176188.
Citri, A., Malenka, R.C., 2008. Synaptic plasticity: multiple forms, functions, and mechanisms.
Neuropsychopharmacology 33, 1841.
Cui, K., Ashdown, H., Luheshi, G.N., Boksa, P., 2009. Effects of prenatal immune activation
on hippocampal neurogenesis in the rat. Schizophr Res 113, 288297. http://dx.doi.
Cui, Z.J., Zhao, K.B., Zhao, H.J., Yu, D.M., Niu, Y.L., Zhang, J.S., Deng, J.B., 2010. Prenatal alcohol
exposure induces long-term changes in dendritic spines and synapses in the mouse vi-
sual cortex. Alcohol Alcohol 45, 312319.
Demirjian, A., Levy, O., 2009. Safety and efcacy of neonatal vaccination. Eur J Immunol
39, 3646.
10 Q. Li et al. / Journal of Neuroimmunology 288 (2015) 112
Di Filippo, M., Sarchielli, P., Picconi, B., Calabresi, P., 2008. Neuroinammation and synap-
tic plasticity: theoretical basis for a novel, immune-centred, therapeutic approach to
neurological disorders. Trends Pharmacol Sci 29, 402412.
El-Husseini, A.E., Schnell, E., Chetkovich, D.M., Nicoll, R.A., Bredt, D.S., 2000. PSD-95 in-
volvement in maturation of excitatory synapses. Science 290, 13641368.
Elkabes, S., DiCicco-Bloom, E.M., Black, I.B., 1996. Brain microglia/macrophages express
neurotrophins that selectively regulate mi croglial prol iferation and function. J
Neurosci 16, 25082521.
Erion, J.R., Wosiski-Kuhn, M., Dey, A., Hao, S., Davis, C.L., Pollock, N.K., Stranahan, A.M.,
2014. Obesity elicits interleukin 1-mediated decits in hippocampal synaptic plastic-
ity. J Neurosci 34, 26182631.
Evans, G.J., Cousin, M.A., 2005. Tyrosine phosphorylation of synaptophysin in synaptic
vesicle recycling. Biochem Soc Trans 33, 13501353.
Figurov, A., Pozzo-Miller, L.D., Olafsson, P., Wang, T., Lu, B., 1996. Regulation of synaptic
responses to high-frequency stimulation and LTP by neurotrophins in the hippocam-
pus. Nature 381, 706709.
Freyne, B.,Curtis, N., 2014. Doesneonatal BCG vaccination prevent allergic diseasein later
life? Arch Dis Child 99, 182184.
Gallagher, C.M., Goodman, M.S., 2010. Hepatitis B vaccination of male neonates and au-
tism diagnosis, NHIS 19972002. J. Toxicol. Environ. Health A 73, 16651677.
Gardoni, F., Boraso, M., Zianni, E., Corsini, E., Galli, C.L., Cattabeni, F., Marinovich, M., Di
Luca, M., Viviani, B., 2011. Distribution of interleukin-1 receptor complex at the syn-
aptic membrane driven by interleukin-1beta and NMDA stimulation. J Neuroinam-
mation 8, 14.
Geinisman, Y., 2000. Structural synaptic modications associated with hippocampal LTP
and behavioral lear ning. Cereb Cortex 10, 952962.
Goshen, I., Kreisel, T., Ounallah-Saad, H., Renbaum, P., Zalzstein, Y., Ben-Hur, T., Levy-
Lahad, E., Yirmiya, R., 2007. A dual role for interleukin-1 in hippocampal-dependent
memory processes. Psychoneuroendocrinology 32, 11061115.
Henneberger, C., Kirischuk, S., Grantyn, R., 2005. Brain-derived neurotrophic factor mod-
ulates GABAergic synaptic transmission by enhancing presynaptic glutamic acid de-
carboxylase 65 levels, promoting asynchronous release and reducing the number of
activated postsynaptic receptors. Neuroscience 135, 749763.
Hodgins, D.C., Shewen, P.E., 2012. Vaccination of neonates: problem and issues. Vaccine
30, 15411559.
Ito, H.T., Smith, S.E., Hsiao, E., Patterson, P.H., 2010. Maternal immune activation alters
nonspatial information processing in the hippocampus of the adult offspring. Brain
Behav Immun 24, 930941.
Jakobsson, H.E., et al., 2014. Decreased gut microbiota diversity, delayed Bacteroidetes
colonisation and reduced Th1 responses in infants delivered by Caesarean section,
Gut microbiota, 2014. Gut 63, 559566.
Jakubs, K.,Nanobashvili, A.,Bonde, S., Ekdahl, C.T., Kokaia,Z., Kokaia, M., Lindvall, O., 2006.
Environment matters: synaptic properties of neurons born in the epileptic adultbrain
develop to reduce excitability. Neuron 52, 10471059.
Kampa, B.M., Letzkus, J.J., Stuart, G.J., 2007. Dendritic mechanisms controlling spike-
timing-dependent synaptic plasticity. Trends Neurosci 30, 456463. http://dx.doi.
Kamphuis, W., Monyer, H., De Rijk, T.C., Lopes da Silva, F.H., 1992. Hippocampal kindling
increases the expression of glutamate receptor-A ip and -B ip mRNA in dentate
granule cells. Neurosci Lett 148, 5154.
Kiros, T.G., Power, C.A., Wei, G., Bretscher,P.A., 2010. Immunization of newborn and adult
mice with low numbers of BCG leads to Th1 responses, Th1 imprints and enhanced
protection upon BCG challenge. Immunother 2, 2535.
Kohman, R.A., Rhodes, J.S., 2013. Neurogenesis, inammation and behavior. Brain Behav
Immun 27, 2232.
Lagranderie, M., Guyonvarc'h, P.M., 2014. The interplay between bacillus CalmetteGue-
rin and Treg cells and its role to prevent or cure inammatory diseases. Expert Rev
Clin Immunol 10, 741745.
Levine, E.S., Dreyfus, C.F., Black, I.B., Plummer, M.R.,1995. Brain-derived neurotrophic fac-
tor rapidly enhances synaptic transmission in hippocampal neurons via postsynaptic
tyrosine kinase receptors. Proc Natl Acad Sci U S A 92, 80748077.
Libraty, D.H., Zhang, L., Woda, M., Acosta, L.P., Obcena, A., Brion, J.D., Capeding, R.Z., 2014.
Neonatal BCG vaccination is associated with enhanced T-helper 1 immune responses
to heterologous infantvaccines. Trials Vaccinology 3, 15.
Liu, L., Wong, T.P., Pozza, M.F., Lingenhoehl, K., Wang, Y., Sheng, M., Auberson, Y.P., Wang,
Y.T., 2004. Role of NMDA receptor subtypes in governing the direction of hippocampal
synaptic plasticity. Science 304, 10211024.
Marchant, A., Goetghebuer, T., Ota, M.O., Wolfe, I., Ceesay, S.J., De Groote, D., Corrah, T.,
Bennett, S., Wheeler,J., Huygen, K., Aaby, P., McAdam, K.P., Newport, M.J., 1999. New-
borns develop a Th1-type immune response to Mycobacterium bovis bacillus
CalmetteGuerin vaccination. J Immunol 163, 22492255.
Min, S.S., Quan, H.Y., Ma, J., Han, J.S., Jeon, B.H., Seol, G.H., 2009. Chronic brain inamma-
tion impairs two forms of long-term potentiation in the rat hippocampal CA1 area.
Neurosci Lett 456, 2024.
Monyer, H., Sprengel, R., Schoepfer, R., Herb, A., Higuchi, M., Lomeli, H., Burnashev, N.,
Sakmann, B., Seeburg, P.H., 1992. Heteromeric NMDA receptors: molecular and func-
tional distinction of subtypes. Science 256, 12171221.
Nakajima, K., Honda,S., Tohyama, Y., Imai, Y., Kohsaka, S., Kurihara, T., 2001. Neurotrophin
secretion from cultured microglia. J Neurosci Res 65, 322331.
Neal-Perry, G., Yao, D., Shu, J., Sun, Y., Etgen, A.M., 2014. Insulin-like growth factor-I reg-
ulates LH release by modulation of kisspeptin and NMDA-mediated neurotransmis-
sion in young and middle-aged female rats. Endocrinology 155, 18271837. http://
Nolan, Y., Maher, F.O., Martin, D.S., Clarke, R.M., Brady, M.T., Bolton, A.E., Mills, K.H., Lynch,
M.A., 2005.Role of interleukin-4 in regulation of age-related inammatory changes in
the hippocampus. J Biol Chem 280, 93549362. http:/ /
Ota, M.O., Vekemans, J., Schlegel-Haueter, S.E., Fielding, K., Sanneh, M., Kidd, M.,
Newport, M.J., Aaby, P., Whittle, H., Lambert, P.H., McAdam, K.P., Siegrist, C.A.,
Marchant, A., 2002. Inuence of Mycobacterium bovis bacillus CalmetteGuérin
on antibody and cytokine responses to human neonatal vaccination. J Immunol
168, 919925.
Ota, M.O., Vekemans, J., Schlegel-H aueter, S.E., Fielding, K., Whittl e, H., Lambert, P.H.,
McAdam, K.P., Siegrist, C.A., Marchant, A., 2004. Hepatitis B immunisation induces
higher antibody and memory Th2 responses in new-borns than in adults. Vaccine
22, 511519.
Palumbo, M.L., et al., 2012. Glatiramer acetate reverts stress-induced alterations on adult
neurogenesis and behavior. Involvement of Th1/Th2 balance. Brain, behavior, and
immunity 26, 429438.
Perry, V.H., 2004. The inuence of systemic inammation on inammation in the brain:
implications fo r chronic neurodegenerative disease. Brain Behav Immun 18,
Pickering, M., Cumiskey, D., O'Connor, J.J., 2005. Actions of TNF-alpha on glutamatergic
synaptic trans mission in the central nervous system. Ex p Physiol 90, 663670.
Prange, O., Murphy, T.H., 2001. Modular transport of postsynaptic density-95 clusters and
association with stable spine precursors during early development of cortical neu-
rons. J Neurosci 21, 93259333.
Schratt, G.M., Tuebing, F., Nigh, E.A.,Kane, C.G., Sabatini,M.E., Kiebler, M., Greenberg, M.E.,
2006. A brain-specic microRNA regulates dendritic spine development. Nature 439,
Schwartz, M., Shechter, R., 2010. Protective autoimmunity fu nctions by intr acranial
immunosurveillance to support the mind: the missing link between health and dis-
ease. Molecular psychiatry. 15, 342354.
Selenica, M.L., Alvarez, J.A., Nash, K.R., Lee, D.C., Cao, C., Lin, X., Reid, P., Mouton, P.R.,
Morgan, D., Gordon, M.N., 2013. Diverse activation of microglia by chemokine (CC
motif) ligand 2 overexpression in brain. J Neuroinammation 10, 86. http://dx.doi.
Shen, H., Huang, H., Wang, J., Ye, S., Li, W., Wang, K., Zhang, G., Wang, P., 2008. Neonatal
vaccination with bacillus CalmetteGuerin elicits long-term protection in mouse-
allergic responses. Allergy 63, 555563.
Spedding, M., Gressens, P., 20 08. Neurotrophins and cytokines in neuronal plasticity.
Novartis Found. Symp. 289, 222233.
ch18 [Discussion, 233240].
Staffend, N.A., Meisel, R.L., 2011. DiOlistic labeling in xed brain slices: phenotype, mor-
phology, and dendritic spines. Curr. Protoc. Neuro sci. .1002/
0471142301.ns0213s55 (Chapter 2: Unit 2.13.).
Süer, C., Dolu, N., Artis, S., Aydogan, S., 2009.Effects of carnosineon long-term plasticity of
medial perforant pathway/dentate gyrus synapses in urethane-anesthetized rats: an
in vivo model. Exp Brain Res 197, 135142.
Taft, C.E., Turrigiano, G.G., 2014. PSD-95 promotes the stabilization of young synaptic con-
tacts Philos. Trans. R Soc. Lond. B Biol. Sci. 369, 20130134.
Thiel, G., 1993. Synapsin I, synapsin II, and synaptophysin: marker proteins of synaptic
vesicles. Brain Pathol 3, 8795.
Urbanska,M., Swiech, L., Jaworski, J., 2012. Developmental plasticity of the dendritic com-
partment: focus on the cytoskeleton. Adv Exp Med Biol 970, 265284. http://dx.doi.
org/10.1007 /978-3-7091-0932-8_12.
Viviani, B., Bartesaghi, S., Gardoni, F., Vezzani, A., Behrens, M.M., Bartfai, T., Binaglia, M.,
Corsini, E., Di Luca, M., Galli, C.L., Marinovich, M., 2003. Interleukin-1beta enhances
NMDA receptor-mediated intracellular calcium increase through activation of the
Src family of kinases. J Neurosci 23, 86928700.
Viviani, B., Gardoni, F., Barte saghi, S., Corsini, E., Facchi, A., Galli, C.L. , Di Luca, M.,
Marinovich, M., 200 6. Interleukin-1 beta released by gp120 drives neural death
through tyrosine phosphorylation and trafcking of NMDA receptors. J Biol Chem
281, 3021230222.
von Bohlen und Halbach, O., Krause, S., Medina, D., Sciarretta, C., Minichiello,L., Unsicker,
K., 2006. Regional- and age-dependent reduction in trkB receptor expression in the
hippocampus is associated with a ltered spine mo rphologies. Bi ol Psychiatry 59 ,
Xia, Y., Qi, F., Zou, J., Yang, J., Yao, Z., 2014a. Inuenza vaccination during early pregnancy
contributes to neurogenesis andbehavioral function in offspring. Brain Behav Immun
42, 212221.
Xia, Y., et al., 2014b. Inuenza A(H1N1)vaccination during early pregnancy transiently
promotes hippocampal neurogenesis and working memory. Involvement of Th1/
Th2 balance. Brain Res 1592, 3443.
11Q. Li et al. / Journal of Neuroimmunology 288 (2015) 112
Yirmiya, R., Goshen, I., 2011. Immune modulation of learning, memory, neural plasticity
and neurogenesis. Brain Behav Immun 25, 181213.
Yong, J., Lacan, G., Dang, H., Hsieh, T., Middleton, B., Wasserfall, C., Tian, J., Melega, W.P.,
Kaufman, D.L., 2011. BCG vaccine-induced neuroprotec tion in a mouse model of
Parkinson's disease. PLOS ONE 6, e16610.
Zhao, C., Teng, E.M., Summers Jr., R.G., Ming, G.L., Gage, F.H., 2006. Distinct morphological
stages of dentate granule neuron maturation in the adult mo use hippocampus. J
Neurosci 26, 311.
Zhu, P.J., Huang, W., Kalikulov, D., Yoo, J.W., Placzek, A.N., Stoica, L., Zhou, H., Bell, J.C.,
Friedlander, M.J., Krnjević, K., Noebels, J.L., Costa-Mattioli, M., 2011. Suppression of PKR
promotes network excitability and enhanced cognition by interferon-gamma-mediated
disinhibition. Cell 147, 13841396.
12 Q. Li et al. / Journal of Neuroimmunology 288 (2015) 112
... Stimulation of the immune system can have varying effects on cognitive function [54]. Studies aimed at assessing the effect of immune stimuli on brain function report: i) the influence of neonatal vaccination on neuronal plasticity and cognitive function under normal physiological conditions in adulthood [55]; ii) the impact of mitogenic and/or inflammatory stimulation of the immune system on the cognitive function of adult mice [56] and neuronal activation [57]; iii) the effect of maternal immune stimulation on the neurocognitive performance of offspring [58]; and iv) the increased risk of neurodegenerative disease development due to inflammatory process [59,60]. ...
... This was associated with increased peripheral and brain levels of IFN-γ and IL-4, neurogenesis and hippocampal BDNF, suggesting a beneficial immunomodulatory effect of immunization on cognitive function [55,61]. Additionally, activation of an anti-inflammatory state of microglia and improvements of cognitive ability have been reported in C57BL/6 mice [62] and rats [54] immunized with BCG. ...
... This suggests that neonatal HBV vaccination may result in detrimental behavioral effects in early adulthood. These data are corroborated by a study by Li et al. [54] who reported similar observations in rats. Inoculation of lipopolysaccharide (LPS) in C57BL/6 mice also increases levels of pro-inflammatory cytokines, mainly TNF-α and IL-1β, and induces infiltration of immune cells into the hippocampus, increased myeloperoxidase activity in the cortex and hippocampus and increased immunoreactivity of microglia and astrocytes, leading to neuronal damage and memory loss [64]. ...
The immune and nervous systems can be thought of as cognitive and plastic systems, since they are both involved in cognition/recognition processes and can be architecturally and functionally modified by experience, and such changes can influence each other's functioning. The immune system can affect nervous system function depending on the nature of the immune stimuli and the pro/anti-inflammatory responses they generate. Here we consider interactions between the immune and nervous systems in homeostasis and disease, including the beneficial and deleterious effects of immune stimuli on brain function and the impact of severe and non-severe malaria parasite infections on neurocognitive and behavioral parameters in human and experimental murine malaria. We also discuss the effect of immunization on the reversal of cognitive deficits associated with experimental non-severe malaria in a model susceptible to the development of the cerebral form of the illness. Finally, we consider the possibility of using human vaccines, largely exploited as immune-prophylactics for infectious diseases, as therapeutic tools to prevent or mitigate the expression of cognitive deficits in infectious and chronic degenerative diseases.
... 8,17 Tissue preparation Preparation of sections was conducted following a previously described method. 18 Briefly, 20% urethane was injected intraperitoneally to anesthetize mice (1.5 g/kg). Thereafter, thoracotomy was performed, and the mice brains were collected and perfused with 2% paraformaldehyde for 2 h. ...
... To analyze the morphology of dendrites and the spines of hippocampal CA1 neurons from 5-month-old mice, the neurons were marked with the fluorescent dye, 1-1'-Dioctadecyl -3,3,3,'3'-tetramethylindocarbocyanine perchlorate (DiI; CM-DiI; Sigma-Aldrich, St. Louis, MO, USA) as previously described. 18 Briefly, 2 mg of DiI was fully mixed with 8 mg of 1.0-µm gold particles (BioRad, Hercules, CA, USA). Given that DiI is soluble in organic solvents, after 300 µL of methylene chloride or dimethylformamide was added to it, a solution was formed. ...
... It was previously reported that BCG exerts neuro-beneficial effects in terms of the physiological status following BCG immunization at a single dose of 1 × 10 5 CFU at P 0 . 18,54 However, in this study, which was conducted as part of a pathological study, a higher dose of BCG (1 × 10 6 CFU) was repeatedly injected into adult APP/PS1 mice. Thus, the different observations made regarding the physiological and pathological status of the neurons possibly resulted from differences in the dose of the living BCG, which then resulted in different types of T cells being stimulated and different Tregs levels. ...
Full-text available
Bacillus Calmette – Guerin (BCG) is an immune regulator that can enhance hippocampal synaptic plasticity in rats; however, it is unclear whether it can improve synaptic function in a mouse model with Alzheimer’s disease (AD). We hypothesized that BCG plays a protective role in AD mice and investigated its effect on dendritic morphology. The results obtained show that BCG immunization significantly increases dendritic complexity, as indicated by the increased number of dendritic intersections and branch points, as well as the increase in the fractal dimension. Furthermore, the number of primary neurites and dendritic length also increased following BCG immunization, which increased the number of spines and promoted maturation. IFN-γ and IL-4 levels increased, while TNF-α levels decreased following BCG immunization; expression levels of p-JAK2, P-STAT3, SYN, and PSD-95 also increased. Therefore, this study demonstrates that BCG immunization in APP/PS1 mice mitigated hippocampal dendritic spine pathology, especially after the third round of immunization. This effect could possibly be attributed to; changes in dendritic arborization and spine morphology or increases in SYN and PSD-95 expression levels. It could also be related to mechanisms of BCG-induced increases in IFN-γ or IL-4/JAK2/STAT3 levels.
... These adjuvants, together with other Al components such as water-soluble Al, are able to induce increased levels of IL-6 in blood and distant organs (i.e., kidney and brain) in both juvenile and adult rodents [183,189,[192][193][194][195][196][197][198]. This effect occurs possibly in response to the oxidative stress induced by Al [192,199]. ...
... Microglial activation-suggesting an ongoing inflammatory process-was observed 6 months after intra-muscular injection of Al oxyhydroxide adjuvant in adult mice ( Figure 2) [164]. Furthermore, neonatal injection of an Al oxyhydroxide-containing HBV vaccine provokes a Th2 immune reaction in the periphery, while raising IL-1β, IL-6, and tumor necrosis alpha (TNF-α) in the hippocampus and impairing hippocampal synaptic plasticity, whereas neonatal Bacille Calmette-Guérin (BCG) immunization provokes the opposite effect [193]. Al-containing hepatitis B injection during the first three weeks of life induces a proinflammatory profile of cytokine expression in the hippocampus [207], whereas in the periphery, it causes increased IL-4 levels and decreased proinflammatory cytokines [208]. ...
... In addition, an adult sheep model also demonstrated that following repetitive shots of ABAs or ABA-containing vaccines, animals exhibited abnormal behaviors, such as increased aggressiveness and stereotypies, and decreased affiliative social interaction [168]. Furthermore, the reported increased levels of IL-6 in the blood and brains of rodents exposed to ABAs [183,193,194] are of particular interest due to the role of this interleukin as an important mediator of autism-like behaviors [60]. As a result of these pieces of evidence (epidemiological, clinical and preclinical data) pointing to a potential causal association between early ABA exposure and increased ASD risk [226], new hypotheses regarding neurological and immunological consequences of ABA-containing vaccines and novel clinical strategies (i.e., postponing of ABA-containing vaccines and replacement of ABAs with calcium phosphate are now being considered [225,229]. ...
Full-text available
Autism spectrum disorder (ASD), schizophrenia, and bipolar disorder are genetically complex and heterogeneous neurodevelopmental disorders (NDDs) resulting from genetic factors and gene-environment (GxE) interactions for which onset occurs in early brain development. Recent progress highlights the link between ASD and (i) immunogenetics, neurodevelopment, and inflammation, and (ii) impairments of autophagy, a crucial neurodevelopmental process involved in synaptic pruning. Among various environmental factors causing risk for ASD, aluminum (Al)containing vaccines injected during critical periods have received special attention and triggered relevant scientific questions. The aim of this review is to discuss the current knowledge on the role of early inflammation, immune and autophagy dysfunction in ASD as well as preclinical studies which question Al adjuvant impacts on brain and immune maturation. We highlight the most recent breakthroughs and the lack of epidemiological, pharmacokinetic and pharmacodynamic data constituting a “scientific gap”. We propose additional research, such as genetic studies that could contribute to identify populations at genetic risk, improving diagnosis, and potentially the development of new therapeutic tools.
... Also, BCG has been reported to confer neuroprotection in a murine model of Japanese Encephalitis by down-regulating the expression of IL-6 and iNOS (Kulkarni et al., 2016). Although many mechanisms have been proposed, a prior study using newborn C57BL/6 mice litters revealed that BCG increased the levels of interferon-gamma (IFN-ϒ), IL-4, BDNF, and IGF-1 proteins in the hippocampus while decreasing the level of IL-6 (Li et al., 2015). These changes can be categorized as having a neurotrophic molecular profile because IFN-ϒ, IL-4, BDNF, and IGF-1 are known to be crucial in neurogenesis. ...
A mutation in the Huntingtin gene causes 'Huntington's disease, which presents as a motor and behavioural impairment. Due to the limited drug therapy for this disease, scientists are constantly searching for newer and alternative drugs that may either retard or prevent the progress of the disease. This study aims to explore the neuroprotective potential of Bacillus Calmette Gaurine (BCG) vaccine against quinolinic acid-induced (QA) neurotoxicity in rats. QA (200 nmol/2µl, i.s) was injected bilaterally into the rat striatum, after which a single dose of BCG (2 ×10^7, cfu) was given to the rats. Animals were assessed for behavioral parameters on the 14th and 21st days. On the 22nd day, animals were sacrificed, brains were harvested, and striatum was separated to evaluate biochemical, inflammatory, and apoptotic mediators. Histopathological studies were performed using Hematoxyline and Eosin staining to assess neuronal morphology. BCG treatment reversed motor abnormalities, reduced oxidative stress and neuroinflammatory markers, apoptotic mediators and striatal lesions induced by QA treatment. In conclusion, treat' 'ing rats with BCG vaccine (2 ×10^7, cfu) mitigated the quinolinic acid-induced Huntington's disease-like symptoms. Hence, BCG vaccine (2×10^7, cfu) could be used as an adjuvant in managing HD.
... Different studies excluded from this review, for instance, because of other irrelevant routes of administration, were nonetheless interesting to briefly consider. Indeed, it has been consistently shown that neonatal intraperitoneal (IP) administration of Al oxyhydroxide-containing HBV vaccine induces a peripheral T helper 2 (Th2) immune response while increasing IL-1b, IL-6, and TNF-a in the hippocampus and hampering hippocampal synaptic plasticity, whereas neonatal Bacille Calmette-Gu erin (BCG) intradermal vaccination induces opposite effects (Li et al. 2015). Recently, it was reported twice that Al-containing hepatitis-B vaccine IP injection during the first three weeks of age interferes with the developing brain in C57BL/6 mice (Yang et al. 2016;Wang et al. 2018). ...
Full-text available
Aluminum (Al) salts are commonly used as adjuvants in human and veterinary vaccines for almost a century. Despite this long history of use and the very large number of exposed individuals, data in the literature concerning the fate of these molecules after injection and their potential effects on the nervous system is limited. In the context of (i) an increase of exposure to Al salts through vaccination; (ii) the absence of safety values determined by health regulators; (iii) the lack of robustness of the studies used as references to officially claim Al adjuvant innocuity; (iv) the publication of several animal studies investigating Al salts clearance/biopersistence and neurotoxicity; we have examined in this review all published studies performed on animals and assessing Al adjuvants kinetics, biodistribution, and neuro-modulation since the first work of A. Glenny in the 1920s. The diversity of methodological approaches, results, and potential weaknesses of the 31 collected studies are exposed. A large range of protocols has been used, including a variety of exposure schedule and analyses methods, making comparisons between studies uneasy. Nevertheless, published data highlight that when biopersistence, translocation, or neuromodulation were assessed, they were documented whatever the different in vivo models and methods used. Moreover, the studies pointed out the crucial importance of the different Al adjuvant physicochemical properties and host genetic background on their kinetics, biodistribution, and neuro-modulatory effects. Regarding the state of the art on this key public health topic, further studies are clearly needed to determine the exact safety level of Al salts.
... In the last few years, evidence has accumulated pointing to the ability of immune stimuli to modulate neurogenesis, synaptic plasticity, in addition to cognitive and behavioral function (Xia et al., 2014;Li et al., 2015;Li et al., 2016;Yang et al., 2016;Qi et al., 2017;Yang et al., 2020;De Sousa et al., 2021). These findings support the concept of consistent communication and interrelationship between the nervous and immune systems, as plastic and cognitive systems (Jerne and Cocteau, 1984;Pert et al., 1985;Cohen, 1992;Sawada et al., 1993;Josefsson et al., 1996;Amenta et al., 2002;McKenna et al., 2002;Daniel-Ribeiro and Martins, 2017) and the use of immunomodulation as a promising approach in the treatment of neurocognitive and behavioral sequelae of infectious diseases. ...
Full-text available
Typical of tropical and subtropical regions, malaria is caused by protozoa of the genus Plasmodium and is, still today, despite all efforts and advances in controlling the disease, a major issue of public health. Its clinical course can present either as the classic episodes of fever, sweating, chills and headache or as nonspecific symptoms of acute febrile syndromes and may evolve to severe forms. Survivors of cerebral malaria, the most severe and lethal complication of the disease, might develop neurological, cognitive and behavioral sequelae. This overview discusses the neurocognitive deficits and behavioral alterations resulting from human naturally acquired infections and murine experimental models of malaria. We highlighted recent reports of cognitive and behavioral sequelae of non-severe malaria, the most prevalent clinical form of the disease worldwide. These sequelae have gained more attention in recent years and therapies for them are required and demand advances in the understanding of neuropathogenesis. Recent studies using experimental murine models point to immunomodulation as a potential approach to prevent or revert neurocognitive sequelae of malaria.
Background Parkinson's disease (PD) is an extrapyramidal movement disorder associated with a hypokinetic condition generated by impairment in dopaminergic neuronal viability in the nigrostriatal region of the brain. Current medications can only provide symptomatic management; to date, no permanent cure is available. To compensate for this lacuna, researchers are gaining interest in antigen‐based therapy, and Bacille‐Calmette‐Guerin (BCG) is one of the vaccines with a high safety margin that acts by stimulating immunoreactive T‐cells in the CNS and reducing expression of pro‐inflammatory cytokines including interleukin (IL)‐1β and tumor necrotic factor (TNF‐α) to produce neuroprotection. A previous study reported that BCG exerts a neuroprotective effect against several neurodegenerative disorders, such as Alzheimer's disease. Objective The objective of this study is to explore the neuroprotective effect of the BCG vaccine against the rotenone model of PD. Methods Rotenone (1.5 mg/kg, s.c ) for 28 days, and BCG vaccine (2 × 10 ⁷ cfu, i.p ) single dose was injected to rats, and behavioral assessments were performed on the 21st and 28th day. On the 29th day, rats were sacrificed, and brains were isolated for biochemical and neurochemical estimation. Results BCG vaccine significantly restored rotenone‐induced motor deficits (open field test, narrow beam walk, and rotarod), biochemical levels (GSH, SOD, catalase, MDA, and nitrite), neurotransmitters (dopamine, 5‐hydroxy tryptamine, norepinephrine, 3,4‐dihydroxyphenylacetic acid, hemovanillic acid, and 5‐hydroxy indoleacetic acid), and levels of inflammatory cytokines (IL‐1β and TNF‐α) in the striatum. It also prevents histopathological changes by reducing eosinophilic lesions in the striatum. Conclusion From the results, we conclude that BCG vaccine showed neuroprotection through antioxidant and anti‐inflammatory effect. Thus, in the future, it can be used as a neuroprotective agent for other neurological disorders, including PD.
Full-text available
La vaccination est une avancée majeure de la médecine moderne ayant permis d’éradiquer certaines maladies et d’endiguer la propagation de nombreuses autres. Malgré une bonne tolérance par la population générale, certains individus présentent des difficultés d’élimination des particules aluminiques utilisées comme adjuvant vaccinaux. Ces patients présentent une lésion histopathologique musculaire caractéristique, biopersistante sur le long terme et composée de cellules immunitaires présentant des inclusions intracellulaires de cristaux aluminiques. Cette lésion, associée à un ensemble d'arthromyalgie, de fatigue chronique et de troubles cognitifs, est appelée myofasciite à macrophages (MFM).Les vaccins à base d’aluminium sont des particules pseudo-infectieuses gérées comme des agents pathogènes par des cellules présentatrices d'antigènes via endocytose et élimination ultérieure par l'intermédiaire de la machinerie xéno/autophagique. Par ailleurs, la littérature scientifique a montré que l’oxy-hydroxyde d'aluminium, l’un des principaux adjuvants, peut perturber la réponse autophagique. Cela conforte l’idée que l’intolérance aux adjuvants aluminiques pourrait être la conséquence d’une interaction de type « gènes x environnement » reposant sur une déficience de l’autophagie dans les cellules de l’immunité comme facteur de susceptibilité individuelle aux particules d’aluminium d’origine vaccinale.Les réponses autophagiques et inflammatoires des cellules immunitaires isolées en réponse aux particules aluminiques n’étant pas totalement caractérisées parmi la population globale. Le travail de thèse présenté dans ce manuscrit a donc eu pour premier objectif d’étudier ces réponses chez des individus sains avant de comparer les résultats avec ceux obtenus chez des individus atteint de MFM. Les données ont démontré que de nombreuses interactions entre les mécanismes d’endocytose, d’autophagie et d’inflammation sont mises en œuvre par les cellules de l’immunité en réponse à la présence de particules d’aluminium. Des expérimentations complémentaires seront nécessaires afin de caractériser finement les différentes intrications entre ces mécanismes. Cependant, certaines observations ont laissé entrevoir de subtiles variations de réponse au sein des cellules immunitaires des patients MFM exposées à des particules aluminiques. Ces cellules ont ainsi présenté un équilibre entre autophagie et endocytose penchant en faveur de l’endocytose et associé à une réponse inflammatoire réduite par rapport aux individus sains. Ces observations sont en accord avec la littérature scientifique actuelle et pourraient être principalement la conséquence plus que la cause de l’état de santé des patients MFM.Suite aux observations in vitro, des analyses exploratoires in vivo ont été menées afin de développer un modèle murin avec des perturbations de l’autophagie pour étudier l’importance de ce mécanisme dans la prise en charge et le devenir des particules aluminiques. Une étude longue a été réalisée pour tester l’efficacité d’un traitement pharmacologique (hydroxychloroquine) à perturber l’autophagie sans induire de toxicité. Nos résultats montrent que, bien qu’apparemment non toxique pour les animaux, le traitement utilisé n’a pas été en mesure de perturber l’autophagie sur le long terme. Par conséquent, l’étude de l’importance du mécanisme autophagique dans la translocation des particules d’aluminium a été réalisée en privilégiant un modèle de KO génétique. Les données ont confirmé les précédentes observations faites sans mettre en avant de rôle majeur de l’autophagie dans le déplacement des particules d’aluminium depuis le site d’injection initial, au regard du faible effectif d’animaux disponibles pour cette étude.En conclusion, ce travail a permis de mettre en évidence une prise en charge des particules aluminiques d’origine vaccinale d’une grande complexité, nécessitant une approche pluridisciplinaire pour être finement décrite.
Bacillus Calmette-Guérin (BCG) is the first developed vaccine to prevent tuberculosis (TB) and is the world's most widely used vaccine. It has a reconcilable defense in opposition to tuberculosis, meningitis, and miliary disease in children but changeable protection against pulmonary TB. Immune activation is responsible for regulating neural development by activating it. The effect of the BCG vaccine on neuronal disorders due to subordinate immune provocation is useful. BCG vaccine can prevent neuronal degeneration in different neurological disorders by provoking auto-reactive T-cells. In the case of TB, CD4+ T-cells effectively protect the immune response by protecting the central defense. Because of the preceding fact, BCG induces protection by creating precise T-cells like CD4+ T-cells and CD8+ T-cells. Hence, vaccination-induced protection generates specific T-cells and CD4+ T-cells, and CD8+ T-cells. The BCG vaccine may have an essential effect on motor disorders and play a crucial role in neuroprotective management. The present review describes how the BCG vaccine might be interrelated with motor disorders and play a key role in such diseases.
Full-text available
Data recently reported by our group indicate that stimulation with a pool of immunogens capable of eliciting type 2 immune responses can restore the cognitive and behavioral dysfunctions recorded after a single episode of non-severe rodent malaria caused by Plasmodium berghei ANKA. Here we explored the hypothesis that isolated immunization with one of the type 2 immune response-inducing immunogens, the human diphtheria-tetanus (dT) vaccine, may revert damages associated with malaria. To investigate this possibility, we studied the dynamics of cognitive deficits and anxiety-like phenotype following non-severe experimental malaria and evaluated the effects of immunization with both dT and of a pool of type 2 immune stimuli in reversing these impairments. Locomotor activity and long-term memory deficits were assessed through the open field test (OFT) and novel object recognition task (NORT), while the anxiety-like phenotype was assessed by OFT and light/dark task (LDT). Our results indicate that poor performance in cognitive-behavioral tests can be detected as early as the 12th day after the end of antimalarial treatment with chloroquine and may persist for up to 155 days post infection. The single immunization strategy with the human dT vaccine showed promise in reversal of long-term memory deficits in NORT, and anxiety-like behavior in OFT and LDT.
Full-text available
The integral SV (synaptic vesicle) protein synaptophysin was one of the first nerve terminal proteins identified. However its role, if any, in the SV life cycle remains undetermined. One of the most prominent features of synaptophysin is that its cytoplasmic C-terminus largely consists of pentapeptide repeats initiated by a tyrosine residue. Synaptophysin is heavily phosphorylated by tyrosine kinases in the nerve terminal, suggesting that this phosphorylation is central to its function. This review will cover the evidence for tyrosine phosphorylation of synaptophysin and how this phosphorylation may control its function in the SV life cycle.
Full-text available
Prenatal influenza virus infection has been associated with an increased risk of schizophrenia. Thus, inactivated flu vaccines are widely recommended for pregnant women. In a mouse model of pregnancy, immune activation via exposure to viruses or lipopolysaccharide (LPS) impaired brain development and behavioral function in offspring. The objective of our study was to determine if flu vaccination as an immune activation could affect postnatal neurogenesis and behavior. Female C57BL/6J mice were administered A(H1N1) influenza vaccine (AIV) or seasonal influenza vaccine (SIV) early in pregnancy. We found that the offspring of vaccinated mice, especially AIV group, presented superior performance in terms of exploratory behavior and spatial ability compared with controls at postnatal day 28 (P28), but at P56, there was no significance differences among these pups. Quantification of BrdU+/DCX+ and BrdU+/NeuN+ cells in the dentate gyrus (DG) indicated an increase in the hippocampal neurogenesis of the pups born to both vaccinated mothers. The cytokine levels in both the serum and hippocampus changed to varying degrees. Furthermore, administration of the A(H1N1) vaccine blocked LPS-induced cognitive impairment in the progeny. Altogether, the results suggest that maternal influenza vaccination promotes neurogenesis and behavioral function, as well as protection from LPS insults in the developing offspring.
Full-text available
Adipose tissue is a known source of proinflammatory cytokines in obese humans and animal models, including the db/db mouse, in which obesity arises as a result of leptin receptor insensitivity. Inflammatory cytokines induce cognitive deficits across numerous conditions, but no studies have determined whether obesity-induced inflammation mediates synaptic dysfunction. To address this question, we used a treadmill training paradigm in which mice were exposed to daily training sessions or an immobile belt, with motivation achieved by delivery of compressed air on noncompliance. Treadmill training prevented hippocampal microgliosis, abolished expression of microglial activation markers, and also blocked the functional sensitization observed in isolated cells after ex vivo exposure to lipopolysaccharide. Reduced microglial reactivity with exercise was associated with reinstatement of hippocampus-dependent memory, reversal of deficits in long-term potentiation, and normalization of hippocampal dendritic spine density. Because treadmill training evokes broad responses not limited to the immune system, we next assessed whether directly manipulating adiposity through lipectomy and fat transplantation influences inflammation, cognition, and synaptic plasticity. Lipectomy prevents and fat transplantation promotes systemic and central inflammation, with associated alterations in cognitive and synaptic function. Levels of interleukin 1β (IL1β) emerged as a correlate of adiposity and cognitive impairment across both the treadmill and lipectomy studies, so we manipulated hippocampal IL1 signaling using intrahippocampal delivery of IL1 receptor antagonist (IL1ra). Intrahippocampal IL1ra prevented synaptic dysfunction, proinflammatory priming, and cognitive impairment. This pattern supports a central role for IL1-mediated neuroinflammation as a mechanism for cognitive deficits in obesity and diabetes.
Full-text available
Neonatal Bacille Calmette Guérin (BCG) vaccination has been reported to have beneficial effects beyond preventing infantile tuberculous meningitis and miliary disease. We hypothesized that BCG vaccine given at birth would enhance T-helper 1 (Th1) immune responses to the first vaccines given later in infancy. We conducted a nested case-control study of neonatal BCG vaccination and its heterologous Th1 immune effects in 2–3 months old infants. BCG vaccination at birth was associated with an increased frequency of interferon-γ (IFN-γ) producing spot-forming cells (SFC) to tetanus toxoid 2–3 months later. The frequency of IFN-γ producing SFC to polioviruses 1–3 also trended higher among infants who received BCG vaccination at birth. The frequency of IFN-γ+/tumor necrosis factor-α (TNF-α)+CD45RO+CD4+ T-cells upon stimulation with phorbol myristate acetate (PMA)/Ionomycin was higher in 2–3 months old infants who received BCG vaccination at birth compared to those who did not. The circulating frequency of forkhead box P3 (FoxP3)+ CD45RO+ regulatory CD4+ T-cells also trended lower in these infants. Neonatal BCG vaccination is associated with heterologous Th1 immune effects 2–3 months later.
Nerve growth factor (NGF) binds to TrkA receptors (neurotrophic) and P75NTR (apoptosis or other pathways depending on the coupled adaptor proteins). Brain derived growth factor (BDNF) can bind to TrkB (neurotrophic) and P75NTR receptors. BDNF is the main, activity-dependent, neurotrophin and sculpts neuronal organisation dependent on activity, thereby coupling and balancing effects on excitatory (glutamate) and inhibitory (GABA) transmission—in a synapse-specific manner. Some drugs can interact in a specific way. Positive modulators of AMPA receptors induce BDNF and favour long term potentiation (LTP) and memory processes. Some antidepressants such as tianeptine reverse stress-induced inhibition of LTP and restore neuronal plasticity in brain areas at risk. Infl ammatory cytokines are produced in sickness behaviour mimicking depression. Interleukin (IL)1β can exacerbate the immediate effects of stressors, and enhance and prolong the overall effects, which may be protective in preventing overuse or by increasing conservation-withdrawal: in some synapses IL1β induces long term depression (LTD) or blocks LTP. The interactions with neurotrophins are complex and frequently reciprocal. However, NGF also contributes to infl ammatory situations and mediates pain responses. This interplay is poorly understood but may be critical in cerebral palsy, neurodegenerative disorders such as amyotrophic lateral sclerosis and multiple sclerosis, and even Alzheimer's disease.
Clinical evidence indicates that Bacillus Calmette-Guérin (BCG) vaccination exerts anti-inflammatory effects in diseases such as asthma, multiple sclerosis or Type 1 diabetes. Although the exact mechanisms for this activity remain debated, the capacity of mycobacteria to induce regulatory T cells (Tregs) in vivo has been widely reported. However, adverse events associated with live BCG prevent its repeated use, especially in immunocompromised individuals. This article reviews the preclinical data showing a potent, systemic and long-term anti-inflammatory effect in animal models of allergic asthma, inflammatory bowel disease and atherosclerosis with a preparation of BCG inactivated by Extended Freeze-Drying (EFD BCG). It also presents the characteristics of EFD BCG-induced Tregs which play a crucial role in the immunomodulation of various inflammatory diseases. Finally, it compares EFD BCG with other approaches based on the therapeutic use of Tregs in humans.
This study investigated potential mechanisms by which age and insulin-like growth factor 1 receptor (IGF1r) signaling in the neuroendocrine hypothalamus affect estradiol positive feedback effects on gonadotropin releasing hormone (GnRH) neuronal activation and on kisspeptin and N-methyl-D-aspartate (NMDA)-induced luteinizing hormone (LH) release, and on the abundance of NMDA receptor subunits Nr1 and Nr2b and Kiss1r transcript and protein in the hypothalamus of young and middle-aged female rats. We infused vehicle, IGF1 or JB-1, a selective antagonist of IGF1r, into the third ventricle of ovariectomized female rats primed with estradiol or vehicle and injected with vehicle, kisspeptin (3 or 30 nmol/kg), or NMDA (15 or 30 mg/kg). Regardless of dose NMDA and kisspeptin resulted in significantly more LH release, GnRH/c-Fos co-labeling and c-Fos immunoreative cells in young than in middle-aged females. Estradiol priming significantly increased Kiss1r, Nr1 and Nr2b receptor transcript and protein abundance in young but not middle-aged female hypothalamus. JB-1 attenuated kisspeptin and NMDA-induced LH release, numbers of GnRH/c-Fos and c-Fos cells, and Kiss1r, Nr1 and Nr2b transcript and protein abundance in young females to levels observed in middle-aged females. IGF1 significantly enhanced NMDA and kisspeptin-induced LH release in middle-aged females without increasing numbers of GnRH/c-Fos or c-Fos immunoreactive cells. IGF1 infusion in middle-aged females also increased Kiss1r, Nr1 and Nr2b protein and transcript to levels that were equivalent to young estradiol-primed females. These findings indicate that age-related changes in estradiol-regulated responsiveness to excitatory input from glutamate and kisspeptin reflect reduced IGF1r signaling.
You are working on the postnatal ward of a busy maternity hospital. While doing a routine discharge check of a newborn baby, the mother asks you about the availability of BCG vaccination. Her two older children have severe eczema, asthma and food allergies, and she has read on the internet that BCG may reduce the risk of allergic disease. In a newborn infant (patient), does BCG vaccination (intervention) prevent the development of allergic disease in later life (outcome)? Medline and Embase were searched (1946 to current date) using the keywords ((bacille Calmette-Guerin) OR (BCG)) AND (allergy OR asthma). Restrictions were human subjects, randomised controlled trials, systematic reviews and meta-analyses. This search yielded 64 articles. A search of the Cochrane Library revealed a further five articles. Of these 69 articles, one randomised controlled trial and four systematic reviews (three with meta-analyses) of observational studies were relevant and selected for full text review. Excluded articles included 10 randomised controlled trials of BCG as an immune therapy for asthma and allergic rhinitis in childhood as they did not relate to the question of prevention. The hygiene hypothesis proposes that diminished microbial exposure in early life prevents the switch from the T helper 2 (Th2) immune response that predominates in neonates to a T helper 1 (Th1) response.1 A persistent …